Light-activated ruthenium (II)-bicalutamide prodrugs for prostate cancer

Zhao, J; Liu, NN; Sun, SC; Gou, SH; Wang, XY; Wang, ZM; Li, XY; Zhang, WJ

Gou, SH (reprint author), Southeast Univ, Res Ctr, Nanjing 211189, Jiangsu, Peoples R China.; Gou, SH (reprint author), Southeast Univ, Sch Chem & Chem Engn, Nanjing 211189, Jiangsu, Peoples R China.; Gou, SH (reprint author), Southeast Univ, Jiangsu Prov

JOURNAL OF INORGANIC BIOCHEMISTRY, 2019; 196 ():

Abstract

Targeted delivery of clinically approved anticancer drug to tumor sites is an effective way to achieve enhanced drug efficacy as well as reduced side ......

Full Text Link